Skip to main content

TIMI Risk Score for NSTEMI

TIMI Risk Score

A Practical Guide for Clinical Use

What is TIMI Risk Score?


The TIMI (Thrombolysis in Myocardial Infarction) Risk Score is a bedside clinical scoring system developed to estimate the risk of death and ischemic events in patients with:


• Unstable Angina (UA) / NSTEMI

• STEMI


It helps in: • Early risk stratification

• Guiding invasive vs conservative strategy

• Predicting 14-day or 30-day outcomes


Developed from the TIMI Study Group trials.



---


1️⃣ TIMI Risk Score for UA / NSTEMI


Developed from the TIMI 11B Trial.


Each variable = 1 point (Total = 0–7)


Variable Criteria


Age ≥ 65 years 1

≥3 CAD risk factors (HTN, DM, smoker, FHx, dyslipidemia)

Known CAD ≥50% stenosis

Aspirin use in past 7 days 1

≥2 angina episodes in 24 hrs 1

ST deviation ≥0.5 mm 1

Elevated cardiac biomarkers Troponin positive




---


Risk Interpretation (14-day risk of death/MI/urgent revascularization)


Score Risk


0–1 ~5%

2 ~8%

3 ~13%

4 ~20%

5 ~26%

6–7 ~41%



Clinical Use


• Score ≥3 → Early invasive strategy preferred

• Score 0–2 → Conservative management may be considered



---


2️⃣ TIMI Risk Score for STEMI


Developed from the InTIME II Trial.


Variables (Weighted Score System)


Variable Points


Age 65–74 2

Age ≥75 3

SBP <100 mmHg 3

HR >100 bpm 2

Killip class II–IV 2

Weight <67 kg 1

Anterior MI or LBBB 1

Time to treatment >4 hrs 1

DM/HTN/Angina history 1




---


Risk Interpretation (30-day mortality)


Score Mortality


0 0.8%

1 1.6%

2 2.2%

3 4.4%

4 7.3%

5 12%

6 16%

7 23%

≥8 35%




---


Why TIMI Score Still Matters


✔ Simple bedside calculation

✔ No calculator required

✔ Validated in multiple cohorts

✔ Useful in resource-limited settings



---


TIMI vs GRACE Score


Feature TIMI GRACE


Complexity Simple Complex

Variables 7 (NSTEMI) 8

Accuracy Good Superior

Guideline preference Acceptable Preferred in ESC



GRACE score derived from the GRACE Registry.



---


Exam Pearls (Cardiology / FCPS / MD)


• TIMI ≥3 (UA/NSTEMI) → Early invasive strategy

• STEMI TIMI >8 → Very high mortality

• TIMI does NOT replace clinical judgment

• GRACE preferred in current ESC guidelines



---


Limitations


• Developed in fibrinolysis era

• Does not incorporate renal function

• Less accurate than GRACE

• Limited precision in contemporary PCI era



---


Bottom Line


TIMI Risk Score is a simple, bedside, rapid stratification tool in ACS.

While GRACE is more accurate, TIMI remains practical and exam-relevant.

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.